“Comparing Continuous and Intermittent Glucose Monitoring Systems for Type 2 Diabetes: HbA1c Reduction, User Satisfaction, and Adverse Events”

https://pubmed.ncbi.nlm.nih.gov/38117991

Continuous and intermittently scanned glucose monitoring systems show a reduction in HbA1c levels in patients with type 2 diabetes, with isCGM associated with improved user satisfaction, but both are linked to increased risk of adverse events.